The poly(A)-binding protein (PABP), bound to the 3 poly(A) tail of eukaryotic mRNAs, plays critical roles in mRNA translation and stability. PABP autoregulates its synthesis by binding to a conserved A-rich sequence present in the 5-untranslated region of PABP mRNA and repressing its translation. PABP is composed of two parts: the highly conserved N terminus, containing 4 RNA recognition motifs (RRMs) responsible for poly(A) and eIF4G binding; and the more variable C terminus, which includes the recently described PABC domain, and promotes intermolecular interaction between PABP molecules as well as cooperative binding to poly(A). Here we show that, in vitro, GST-PABP represses the translation of reporter mRNAs containing 20 or more A residues in their 5-untranslated regions and remains effective as a repressor when an A 61 tract is placed at different distances from the cap, up to 126 nucleotides. Deletion of the PABP C terminus, but not the PABC domain alone, significantly reduces its ability to inhibit translation when bound to sequences distal to the cap, but not to proximal ones. Moreover, cooperative binding by multiple PABP molecules to poly(A) requires the C terminus, but not the PABC domain. Further analysis using pull-down assays shows that the interaction between PABP molecules, mediated by the C terminus, does not require the PABC domain and is enhanced by the presence of RRM 4. In vivo, fusion proteins containing parts of the PABP C terminus fused to the viral coat protein MS2 have an enhanced ability to prevent the expression of chloramphenicol acetyltransferase reporter mRNAs containing the MS2 binding site at distal distances from the cap. Altogether, our results identify a proline-and glutamine-rich linker located between the RRMs and the PABC domain as being strictly required for PABP/PABP interaction, cooperative binding to poly(A) and enhanced translational repression of reporter mRNAs in vitro and in vivo.
The poly(A)-binding protein (PABP) 1 bound to the 3Ј poly(A) tail of eukaryotic mRNAs is now recognized as an important if not an essential component of the apparatus required for mRNA translation. Evidence from yeast, plant, and animal models has shown a role for the PABP-poly(A) complex in translation initiation and points to a synergism between the 3Ј and 5Ј ends of the mRNAs (through the cap-and poly(A)-associated proteins) in promoting translation (reviewed in Refs. [1] [2] [3] [4] . The demonstration of an interaction between the translation initiation factor eIF4G and PABP provides an elegant explanation as to how this synergism occurs (5) . Simultaneous binding of eIF4G to both PABP and eIF4E (the capbinding protein) leads to a circularization of the mRNA, as seen by atomic force microscopy, which may enhance its ability to undergo re-initiation (6) . The PABP-poly(A) complex has also been implicated in the control of mRNA stability in yeast (reviewed in Refs. 7 and 8) and in mammals (9, 10) .
PABP consists of a highly conserved N terminus containing four tandem RNA recognition motifs (RRM) followed by a more variable C terminus (for review, see Ref. 4) . The first two RRMs are sufficient for specific poly(A)-binding (11) (12) (13) (14) . In addition, RRM2 promotes the interaction between PABP and eIF4G (15) (16) (17) . RRM4 is responsible for most of the nonspecific RNA binding of PABP (12, 13) ; in yeast the first half of RRM4 is sufficient to confer viability to cells depleted of the normal PABP gene (11) . In Xenopus oocytes, RRMs can stimulate translation when tethered to reporter mRNA (18) . As to the C terminus, although it does not bind RNA, it enables PABP to multimerize on poly(A) (12) . Recently it was shown to include a domain responsible for binding to the PABP-interacting proteins Paip1 and Paip2 as well as to the release factor eRF3 (19) . This 74-residue domain (called PABC) is conserved in all PABPs described so far (from protists to vertebrates) and is also present in the hyperplastic discs protein (HYD) family of ubiquitin ligases (20) . The structures of both human PABC and its HYD homologue confirmed it as a novel phylogenetically conserved domain responsible for protein-protein interactions (19, 20) . The C terminus can contribute to mRNA stabilization (21) and also plays a role in the nuclear export of PABP bound to newly synthesized poly(A)-containing RNA (22) .
PABP expression is regulated at the translational level. PABP mRNA is a member of the 5Ј-terminal oligopyrimidine tract mRNA family (23) , which includes mRNAs encoding components of the protein synthesis machinery. Translation of these mRNAs is linked to the growth status of the cell, and this regulation strictly requires a short sequence of polypyrimidines at their 5Ј end (reviewed in Ref. 24) . Control of PABP expression is also achieved through an autoregulatory mechanism whereby PABP binds to an A-rich tract present in the 5Ј-UTR of its mRNA and represses its own synthesis, when in excess over poly (A) ϩ RNA (25) (26) (27) (28) . The A-rich tract, 50 -70 nt long, is found in almost all PABP mRNAs (25, 29, 30) . In the human mRNA, the 61-nt-long tract contains sets of 5-8 A residues interspersed by 3-6 pyrimidine residues and is located 73 nucleotides from the cap (23) . Repression by PABP may be relieved when there is an increase in the intracellular poly(A) ϩ mRNA, or an increase in the length of pre-existing poly(A) tails. Addition of exogenous poly(A) mimics this effect and specifically stimulates PABP synthesis in vitro in the absence of mRNA synthesis (25) , whereas overexpression of PABP in vivo leads to the translational repression of endogenous PABP mRNA (27, 28) .
The prototype mechanism for translational repression of mRNAs by 5Ј-UTR-bound proteins is that described for ferritin mRNA. Regulation of ferritin mRNA translation is mediated by a stem-loop structure called the IRE (iron regulatory element) and its binding factor, the iron regulatory protein (IRP; for reviews, see Refs. 31 and 32) . The IRE-IRP complex represses ferritin mRNA translation by precluding the recruitment of the small ribosomal subunit (33) . To be effective in vivo and in the rabbit reticulocyte lysate cell-free system, the IRE motif must be located within 60 nucleotides of the mRNA cap structure (34, 35) . When placed further from the cap, the IRE-IRP complex delays productive scanning of the ribosomal subunit along the mRNA 5Ј-UTR, but without greatly compromising overall translation (36) . In contrast, in plant or yeast extracts, which lack endogenous IRP, a cap-distal IRE-IRP complex can arrest ribosomal scanning and efficiently inhibit translation (36, 37) . As to PABP-mediated translational repression, recent evidence indicates that, in HeLa cells, PABP bound to the A-rich tract in the reporter mRNA 5Ј-UTR, up to 200 nt from the 5Ј cap, stalls the migration of the 40 S ribosomal subunit along the mRNA, preventing it from reaching the AUG and forming the elongating 80 S complex (38) .
In this study, we examined the requirements of the PABP molecule to act as a translational repressor of reporter mRNAs containing A-tracts in their 5Ј-UTR. We confirm the lack of positional requirement for effective inhibition by wild type PABP (38) . Moreover, we observe that PABP variants lacking the C terminus are much less efficient in repressing the translation of mRNAs carrying cap-distal A-tracts. These PABP variants have affinities for poly(A) similar to that of the fulllength protein, but have a reduced ability to associate cooperatively to poly(A). We go on to show a correlation between the presence of the fourth RRM and part of the C terminus, but not including the PABC domain, and the ability of PABP to associate cooperatively to poly(A), multimerize, and enhance PABPmediated translational repression.
EXPERIMENTAL PROCEDURES
Cyclin Reporter Plasmids-The cyclin mRNAs described in this study were based on the Xenopus cyclin A cDNA in the plasmid pTZ18R, which contained a tract of 61 A residues, located 41 nucleotides from the 5Ј end of cyclin mRNA (25) . In this and in the following constructs, the cyclin cDNA is missing the end of its 3Ј-UTR (ϳ80 nt) and it lacks a 3Ј poly(A) tail (we have seen that the presence or absence of such a tail does not affect translation inhibition/stimulation by poly(A)). To reduce the A tract length, this plasmid was digested with StuI and XbaI and the longer fragment, devoid of the original A tract, was ligated to pairs of oligonucleotides designed to reduce the number of A residues to 20 or 10 nucleotides (5Ј primers: 5Ј-CCTA 20 T-3Ј and 5Ј-CCTA 10 T-3Ј). To reduce the distance between the transcription initiation site and the start of the A tract, the original plasmid was digested with EcoRI and StuI, treated with T4 DNA polymerase, and religated (distance cap/A tract of 10 nucleotides). To increase the distance, the starting plasmid was digested with KpnI and BamHI and ligated with the 62-bp KpnI/ BamHI fragment from plasmid Bluescript II KSϩ from Stratagene. This plasmid was then digested with XhoI and ClaI, treated with T4 DNA polymerase, and then either religated (distance 86) or ligated with either one or two copies of the 40-nt StuI/SacII fragment obtained from the human PABP cDNA 5Ј-UTR (distances 126 and 166). All plasmid constructions were confirmed by sequencing.
In Vitro Transcription and Translation-Transcriptions were performed as described previously (25) , using T7 RNA polymerase with SalI (cyclin) or BamHI (PABP) linearized plasmid DNAs. For the translation reactions, the rabbit reticulocyte cell-free system (Promega) was treated with micrococcal nuclease to render it mRNA-dependent. In vitro transcribed RNAs were translated at the final concentrations indicated in the figures. Protein synthesis was assayed at 30°C with [ 35 S]methionine (Amersham Biosciences) and the radiolabeled products analyzed by 15% SDS-polyacrylamide gel electrophoresis and autoradiography. When used, polynucleotides were pre-incubated with the reticulocyte mix for 15 min on ice, prior to addition of mRNA, followed by incubation at 30°C for 1 h. For the translations with the added proteins, mRNAs were pre-incubated with the GST fusion proteins and ribonuclease inhibitor (final concentration of ϳ200 units/ml in the translation reaction) on ice for 15 min in the presence of Escherichia coli rRNA (2.5 mg/ml) and poly(G) or poly(C) (at 2 mg/ml final) as nonspecific competitors, prior to the addition of the translation extract. All the translation results shown are representative of various experiments performed with different batches of mRNAs and proteins, and the data were highly reproducible in trend from experiment to experiment. Repeating the experiments with the same mRNA/protein batches produced identical results.
GST-PABP Expression Plasmids-The plasmid encoding human PABP (construct P10 -636, missing the first nine codons), cloned into the BamHI site of pGEX2T, has been described (25) . Clones encoding the PABP variants P10 -584, P10 -370, and P372-636 were obtained by PCR using an annealing temperature of 50°C for 30 cycles. As 5Ј primer for variants P10 -584 and P10 -370, the oligonucleotide 6291 (5Ј-CGGGATCCCTGCGGGCAGCCG-3Ј), which anneals immediately upstream of the PABP translation initiation codon, was used. The 3Ј oligonucleotides, 3771 and 3772, which are complementary to sequences coding for conserved motifs present at the end of the fourth RRM (3Ј end of P10 -370) and in the second half of the C terminus (3Ј end of P10 -584), have been described previously (39) . To clone fragments P10 -584 and P10 -370 into the pGET2T expression vector, the PCR fragments were digested with NcoI (which cuts on the second methionine at amino acid position 10) and BamHI, prior to in-filling and ligation into the in-filled BamHI-cut pGEX2T vector (Amersham Biosciences). The P372-636 PCR fragment was amplified with the oligonucleotides 7736 (5Ј-CCGGGATCCGAAGAGCGCCAGGCT-3Ј) and 7737 (5Ј-CGGAATTCTAGATATTTTTCTTCGGTG-3Ј) and inserted into the BamHI/EcoRI sites of the pGEX2T vector. The P10 -370 plasmid was further digested with EcoRI and the larger fragment gel religated to yield the P10 -190 plasmid. P237-636 was the result of digesting the plasmid coding for wild type PABP with NcoI/HindIII followed by infilling and religation of the plasmid-containing fragment. P10 -542 was obtained by site directed mutagenesis of the P10 -636 plasmid to replace the glutamic acid at position 543 with a stop codon. Mutagenesis was performed with the QuikChange TM site-directed mutagenesis kit (Stratagene). Likewise, P237-542 was obtained from P237-636 by the introduction of the same mutation. All plasmid constructions were confirmed by sequencing. Protein expression and purification has been described previously (25) .
Band-shift Assays-The RNA probes used in the band-shift assays were synthesized from linearized plasmids using T7 RNA polymerase and [␣-32 P]ATP (Amersham Biosciences). Band-shifts were performed as described by Walker et al. (40) with minor modifications. Briefly, 10-l reactions were carried out in microtiter plates. The labeled probes were initially denatured by incubation at 95°C for 3 min and then, following rapid cooling, were incubated with different concentrations of the recombinant proteins for 15 min on ice in the presence of binding buffer (5 mM Hepes, pH 7.2, 1.5 mM MgCl 2 , 2.5% glycerol, and 0.5 mM dithiothreitol), 250 g/ml competitor E. coli rRNA, 100 mM KCl, 1 mg/ml BSA, and RNase inhibitor (2.5 units). Heparin was then added to 5 mg/ml followed by 2 l of loading buffer (48.5% glycerol and 0.5% each of bromphenol blue and xylene cyanol). Samples were then immediately run on nondenaturing polyacrylamide gels (acrylamide/bisacrylamide ratio of 60:1) in 0.5ϫ TBE, the gels having been previously pre-run for 15-30 min at 200 -300 volts. Electrophoresis was performed at 4°C, followed by autoradiography.
Pull-down Assays-The glutathione-Sepharose beads (Amersham Biosciences) were initially pre-washed with binding buffer (BB: 150 mM KCl, 5 mM MgCl 2 , 10 mM Hepes, pH 7.2, 0.2% Nonidet P-40) and saturated with 10 mg/ml BSA in BB for 30 min at 4°C, followed by two more washes with BB. Approximately 20 l of the beads were incubated with 4 g of the GST-PABP variants in a final volume of 100 l for 30 min at room temperature. The beads were then washed two times with BB containing 4 mg/ml BSA and incubated with 10 l of translation extract for 30 min at room temperature and washed twice again with BB. Proteins bound to the beads were eluted by addition of SDS-PAGE sample buffer and the samples run on 15% SDS-PAGE, followed by Coomassie Blue staining and autoradiography. Labeled cyclin A and PABP were synthesized in the TNT T7 coupled reticulocyte lysate system (Promega) using 5 g/ml amounts of each plasmid. The labeled PABP deletions were obtained by linearizations of the wild type PABP cDNA with HindIII (1-237), MscI (1-358), or Tth111I (1-432) (the numbers indicate the amino acids retained from full-length PABP), followed by transcription with T7 RNA polymerase in the presence of the cap analogue and translation in the rabbit reticulocyte lysate. In some cases, prior to their use in the pull-down assays, the reticulocyte lysates were treated with either 100 units/ml cobra venom RNase (RNase V 1 ; Amersham Biosciences) for 30 min at 37°C or with 250 units/ml micrococcal nuclease for 20 min at 20°C in the presence of 1.5 mM CaCl 2 followed by addition of EGTA to 6 mM. Both RNases efficiently degraded commercial poly(A) (data not shown). When specified, the lysates were also supplemented with E. coli rRNA (250 g/ml), poly(A) (5 or 20 g/ml), or poly(C) (20 g/ml).
Pull-downs with the His-tagged proteins were carried out as described above but using the Ni-NTA resin (Qiagen). Labeled human eIF4G was obtained by subcloning the XbaI/HindIII fragment from plasmid pSK-HFC1 (41) into the same sites of the pBluescript KS vector (Stratagene), followed by linearization with HindIII and in vitro transcription and translation as described above. His-tagged human eIF4A from plasmid pET(His 6 -eIF4A) (42) and MS2/PABP-(372-636) were expressed and purified on Ni-NTA resin as recommended.
MS2 Tethering Constructs-The reporter plasmids MSC-15 and MSA-15 were obtained by digestion of the MSC-GH and MSA-GH plasmids (43) with XbaI/HindIII and ligation of the larger fragment to the BamHI/HindIII fragment encoding the CAT gene from plasmid pSV2-CAT. Both the vector and insert DNAs were in-filled with Klenow DNA polymerase prior to ligation. The MSC-91 plasmid was constructed by inserting a BamHI/XbaI insert from the polylinker region of plasmid pcDNA3 (Invitrogen) into the BamHI site of MSC-15. In this case, the BamHI ligation was performed first, followed by the in-filling of the protruding ends and a second round of ligation.
To produce the effector plasmids, the DNA fragments encoding the various PABP deletions originally in the pGEX2T vector were first cloned into the pET-MS2 plasmid (21) to generate MS2-PABP fusions. Subcloning the in-filled BamHI PABP fragments from P372-636 and P237-584 into the BamHI site of pET-MS2, also in-filled, yielded MS2/ PABP-(372-636) and MS2/PABP-(237-584), respectively. The resulting plasmids were then digested with XbaI/EcoRV, in-filled, and the inserts transferred to the EcoRV site of the eukaryotic expression vector pcDNA3, under the control of the cytomegalovirus promoter. All cloning steps and the final coding frames were confirmed by sequencing.
Transfection Assays-Approximately 4 ϫ 10 5 human embryonic kidney cells (293-EBNA-BCRJ) were grown in each well of the 24-well dishes with Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum, streptomycin (100 g/ml), and penicillin (60 g/ml). Subconfluent cultures were transfected in DMEM without serum and antibiotics. Transfections were performed with 250 ng of reporter plasmid, 20 ng of pCMV␤ control plasmid (Clontech), and 2.5, 5, or 10 ng of effector plasmid (for the first two concentrations of the effector plasmid DNA, the difference to 10 ng was supplemented with DNA from the empty pcDNA3 vector). The plasmids were transfected along with LipofectAMINE (Invitrogen) as recommended by the manufacturer, and the transfected cells were allowed to grow for ϳ36 h in DMEM plus 10% fetal calf serum and antibiotics. Prior to harvesting, the cells were washed twice with phosphate-buffered saline. Cells were lysed with lysis buffer (100 mM Tris-HCl, pH 7.8, 0.5% Triton X-100) for 15 min at 37°C, and the clarified supernatant was assayed for CAT and ␤-galactosidase activities using standard methods (44) .
For the RNA expression analysis, 5-fold transfection reactions were carried out using the MSC-91 reporter plasmid with the highest concentration of effector plasmid tested. Approximately 15% of the transfected cells were processed and assayed for CAT and ␤-galactosidase. The remaining transfected cells were extracted with TRIzol (Invitrogen), and the total RNA was digested with RNase-free DNase I (Amersham Biosciences) and then run on denaturing formaldehyde gels prior to Northern blotting. The following DNAs were used as probes: the 0.7-kb XbaI/HindIII fragment of pET-MS2, the 1.6-kb HindIII/BamHI fragment of pSV2-CAT, the 2.4-kb NcoI/SmaI fragment of pGEX2T-PABP, and the 3.5-kb ScaI/NotI fragment of pCMV␤ containing the ␤-galactosidase gene. Probes were labeled with [␣-32 P]dCTP using the Megaprime kit (Amersham Biosciences).
RESULTS

Requirements for Translational Regulation of Reporter mRNAs Containing 5Ј-UTR A-tracts-
To study the role of the A-rich region of the PABP mRNA 5Ј-UTR in PABP-mediated translation repression, we previously used mRNA reporters containing A-rich sequences followed by the coding region of Xenopus cyclin A (25) . Here, we first examined the effect of varying the length of the A-tracts upstream of the cyclin reporter mRNAs, by comparing the effect of 10, 20, and 61 A residues in the 5Ј-UTR. The longest tract is the same length as the entire A-rich region in the human PABP mRNA leader region. The assay is based upon the ability of endogenous reticulocyte PABP to repress translation of the A-tract containing reporter mRNAs. We have shown that the presence of the 5Ј-UTR A-tract is associated with a reduced translation efficiency of the reporter mRNAs, as a result of bound PABP, as compared with control RNAs devoid of the adenylate sequence. Addition of exogenous poly(A) stimulates the translation of these mRNAs in the reticulocyte system by titrating the PABP bound to their 5Ј-UTR (25) . An internal control mRNA, which lacks any regulatory elements in the leader region, ⌬(1-263) PABP, is included in the translation assay (25) .
Translation of cyclin mRNAs containing in their 5Ј-UTR either 10, 20 or 61 A residues, at a fixed position relative to the cap (41 nt), was assayed in the absence or presence of increasing amounts of added poly(A) (Fig. 1A) . First, we noted that, in the absence of poly(A) competitor, increasing the chain length of A residues progressively reduced the efficiency of translation of cyclin mRNAs, relative to the control mRNA, presumably reflecting enhanced PABP binding. The 10-A-containing cyclin mRNA was not affected by the addition of poly(A), except at the highest doses, which inhibited the translation of the various cyclin reporters and the control RNA. As has been described previously (25, 45) , inhibition of translation by poly(A) presumably occurs through a depletion of the lysate PABP, because this inhibition can be reversed by addition of the purified protein (45) . The translation of both the 20-and 61-A-containing cyclin mRNAs was stimulated at intermediate poly(A) levels, with similar degrees of stimulation observed for both mRNAs (Fig. 1B) . These data are entirely consistent with the finding that PABP can bind oligo(A) sequences as short as 12 nt (11, 12) in vitro. Next, we investigated the importance of the position of the adenylate tract, relative to the 5Ј end of the mRNA, to the translation of reporter mRNAs. Cyclin RNAs were obtained, which contained 61 A nucleotides placed at various distances from the cap, ranging from 10 to 166 nt. Stimulation of translation by added poly(A) was observed in all five distance reporter mRNAs, although the degree of enhancement was somewhat less efficient in the most cap-distal mRNAs, with A-tracts at 126 and 166 nt from the cap (Fig. 1 (C  and D) and data not shown). This difference possibly reflects the presence of additional sequences in the cap-distal mRNAs, or a reduced efficiency of the translation of the mRNAs con-taining longer UTRs in the reticulocyte lysate. We conclude that PABP-mediated repression in vitro requires more than 10 As in the leader region, and that it can operate even when the A-tract is distal to the cap. This result is in agreement with recently published data (38) , as well as with the distance of 73 nucleotides from the cap to the A-tract in the human PABP mRNA (23) .
RRM 3/4 and the C Terminus of PABP Are Required for Efficient Cap-distal Repression-To assess the contribution of the different domains of PABP, including the C terminus, to its activity as a repressor of translation, a series of different deletions in the PABP gene were prepared and the resulting proteins fused to GST were expressed in E. coli. Fig. 2A shows a scheme describing the different deletions obtained during this study, each named according to the number of the amino acids retained from the wild type protein. The various proteins were purified by affinity chromatography and quantified by SDS-PAGE (see Fig. 2B for a selection of the various proteins used in this study, as well as Fig. 5A (upper panel) ).
Wild type GST-PABP (P10 -636) and the variant with the whole of its C terminus deleted (P10 -370) were initially tested in in vitro translation assays with the cyclin reporter mRNAs described in Fig. 1 . First, the RNAs with differing lengths of A-tracts were tested with the full-length GST-PABP (P10 -636) and the P10 -370 variant. Both proteins were able to repress the translation of RNAs containing either 61 or 20 A nt. As expected, neither significantly affected the translation of the reporter containing 10 A nt in the 5Ј-UTR (data not shown), in agreement with the results in Fig. 1A . In contrast, when the RNAs containing variations in the distance between the cap and the 61-nt A-tract were translated in the presence of increasing amounts of PABP variants, a significant difference could be seen between the two proteins (Fig. 3, A and B) . Full-length PABP efficiently repressed the translation of all the distance constructs up to 126 nucleotides, but the PABP variant lacking the C terminus (P10 -370) was a much less effective repressor at A-tract distances greater than 41 nucleotides. This difference was not at the level of RNA binding, as P10 -636 and P10 -370 were equally able to bind 32 P-labeled probes consisting of the 5Ј-UTR of the different cyclin mRNAs in a gel-shift assay (Fig. 3C) . Strikingly, the PABP variant P10 -190, which contains only the first two RRMs required and sufficient for specific binding to poly(A) (12, 14) , could only effectively repress the translation of the reporter RNA containing the most cap-proximal A-tract, at the highest doses tested (Fig. 3, D and E) . We conclude that efficient repression of cap-distal A-tract mRNA requires some or all of RRM3/4 and is greatly enhanced by the C terminus.
Mapping the Domains Required for Cooperative Binding of PABP to Poly(A)-
The PABP C terminus confers homodimerization activity on PABP, bound to poly(A), as shown by bandshift assays in which labeled A 23 probes (sufficient to bind only one PABP molecule) formed multiple complexes at saturating concentrations of PABP, but not of a variant only containing the four RRMs (12) . This band-shift strategy was used to assay for homodimerization of various GST-PABP proteins in the presence of a labeled poly(A) probe corresponding to the 61-ntlong PABP 5Ј-UTR A-rich sequence (Fig. 4A) . From the work of Kuhn and Pieler (12), we reasoned that this sequence is capable of binding three (possibly four) PABP molecules. Upon incubation with increasing concentrations of GST-PABP, (ranging from 4 to 260 nM), we observed multiple shifted complexes indicative of sequential filling of binding sites in a cooperative manner (Fig. 4B, P10 -636) . We estimate the K d of the PABP proteins bound to the labeled probe to vary between 5 and 15 nM, which are very similar values to those obtained previously (12, 13, 46) . To map the region involved in the PABP/PABP interaction, GST fusion proteins containing Cterminal deletions (P10 -584, P10 -542, and P10 -370) were used in comparison to GST-PABP. In full-length PABP and the variants lacking part of or the complete PABC domain (P10 -584 and P10 -542 respectively), binding of one molecule to the probe was an intermediate stage followed at higher concentrations by binding of two, three, or even more molecules. In contrast, P10 -370, although having an affinity to poly(A) similar to that of these proteins, differed significantly from them in that multiple binding of the protein to the probe RNA was substantially impaired. Thus, even at the highest concentration of P10 -370, a significant proportion of the probe was bound by only one molecule and two molecules seemed to be the most that could bind the probe (Fig. 4B) . Similar results were observed in the case of an A 61 RNA probe, although here we noted an increased efficiency of cooperative PABP/PABP interactions, which prevented detection of intermediate complex formation (data not shown).
In the translation repression assay, the new variant P10 -542, although lacking the PABC domain, was observed to be nearly as active as the full-length protein in the repression of reporter mRNAs with the A tract distal to the cap, with a reduction in repression efficiency only at the 126-nt distance (Fig. 4C) . We conclude that the PABP C terminus, excluding the PABC domain, is involved in cooperative PABP/PABP binding in the presence of poly(A) and enhances PABP activity as repressor of translation.
PABP C Terminus, the Fourth RRM, and Poly(A) Are Required and Sufficient for Specific PABP/PABP Interaction-
The experiments above point to the region between amino acids 370 -542 as being involved in mediating PABP/PABP interactions and enhancing translational repression. To confirm these results, we used pull-down assays in which PABP variants were bound to glutathione-Sepharose beads and subsequently incubated in the presence or absence of poly(A) with 35 S-labeled full-length PABP translated in rabbit reticulocyte lysate. A second 35 S-labeled protein, cyclin A, was included in the reaction as a control to monitor for nonspecific bead binding. Following incubation, and washing, the proteins bound to the beads were analyzed by SDS-PAGE, and Coomassie Blue staining and autoradiography. The top panel in Fig. 5A shows that approximately equal amounts of GST-PABP variants were bound and eluted from the beads. As shown in the middle and bottom panels of Fig. 5A , weak and equal cyclin protein binding is observed in all lanes (this nonspecific binding was consistently enhanced following ribonuclease treatment, for unknown reasons). In the presence of poly(A), all N-terminal GST-PABP variants containing at least RRM1/2 pull down 35 S-labeled PABP. Comparison with an aliquot of the initial translation mix (Retic lane) allows us to estimate that approximately 20% of the 35 S-labeled PABP is bound by GST-PABPs. Variants P237-542 and P237-636, which include a complete RRM4 plus the 370 -542 part of the C terminus, identified as necessary for cooperative binding to poly(A) (Fig. 4) , or the whole of the C terminus, respectively, also interact with the translated PABP. In contrast, variant P372-636, which only consists of the PABP C terminus, interacts very weakly. This level of binding was well above background binding; as shown in the control lanes, labeled PABP did not bind immobilized GST or glutathione-Sepharose beads. In the absence of poly(A), and with the addition of cobra venom RNase to degrade any remaining excess RNA, most of the fusion proteins, including full-length GST-PABP, lose the ability to interact with 35 S-PABP. Surprisingly, the P237-542 and P237-636 variants still retain the capacity to bind to the labeled protein, suggesting that the removal of the first three RRMs from at least one of the binding molecules relieves an inhibitory mechanism, which prevents PABP/PABP binding in the absence of poly(A). The same results were obtained in several independent experiments, some using micrococcal nuclease in place of cobra venom RNase (data not shown).
To rule out the possibility that the P237-636 and P237-542 proteins bind full-length PABP through an RNA bridge (at least when poly(A) is present), we tested their ability to bind 32 P-labeled A 61 RNA probes using band-shift assays (performed as described in Fig. 4B ). The P372-636, P10 -636, and P10 -370 PABP variants were also included in this experiment as controls (Fig. 5B) . Only the proteins containing functional RRMs 1 and 2 bound the A-tract probe, indicating that the P237-636 and P237-542 variants bound full-length PABP directly. We next tested the ability of GST-PABP variants to bind truncated PABP proteins, labeled in vitro, to determine the minimal optimal interaction region. Three different mRNAs, coding for sequential C-terminal PABP deletions, which lack the PABC domain, the whole of the C terminus, and the fourth RRM plus the C terminus, respectively (see Fig. 2A for exact positions of the deletions), were initially co-translated in the rabbit reticulocyte lysate. Following translation, the reaction was treated with micrococcal nuclease, to remove any remain- ing RNA, and excess ribosomal RNA was added as nonspecific competitor, after the addition of EGTA to quench micrococcal nuclease activity. The reaction was then divided into two aliquots, and either poly(A) or poly(C) was added prior to incubation with various bead-bound GST-PABPs (Fig. 5C ). In the presence of poly(A), the three GST-PABPs bring down the three labeled proteins at equivalent levels, compared with their initial reticulocyte levels. Indeed, as observed previously (Fig.  5A) , P237-636, although not able to bind poly(A) (Fig. 5B) , is as efficient as the P10 -370 and P10 -636 proteins that do bind poly(A) (Fig. 5C ). Even the 1-237 labeled protein that lacks the entire C terminus and the fourth RRM is brought down in similar proportions to the longer proteins. (We also note that the minor labeled proteins, truncated versions of PABP arising /ml) . B, the autoradiograms shown in A were quantitated and analyzed as in Fig. 1 , but here for each experiment the ratio between the intensities of the cyclin and the control PABP bands was plotted as a function of the GST-PABP concentration, normalizing as 1 (dashed line) the value obtained in the absence of GST-PABP (non-normalized cyclin/control ratios of 3.05, 2.95, 1.2, and 0.55 for the 10-, 41-, 86-, and 126-nt distance mRNAs, respectively). C, band-shift analysis with the 5Ј-UTR of the cyclin mRNAs used in the translation assays. The various cyclin DNA constructs tested in A and B, linearized after the cyclin ATG (StyI site), were transcribed in the presence of [␣-
32 P]ATP. The resulting labeled RNAs (10,000 cpm or ϳ0.7 ng) were incubated with either wild type GST-PABP or the P10 -367 variant (14 g/ml final concentration) and the protein-RNA complexes analyzed on 4% nondenaturing polyacrylamide gels. ORF, open reading frame. D, translation repression assay of PABP variant P10 -190 (0, 2.6, 5.3, and 10.5 g/ml) with the 10-, 41-, and 86-nt distance cyclin mRNAs tested in A. E, the results from D were quantitated and plotted as in B (non-normalized cyclin/control ratios of 3.2, 2.8, and 2.15 for the 10-, 41-, and 86-nt distance mRNAs, respectively). The stimulation observed for the 86-nt distance in the last concentration (10.5 g/ml) is not reproducible and is only observed in cyclin/control ratio because of a small decrease in the control PABP band in the last lane of the experiment. In all translation assays, the concentration of the control mRNA was 0.25 g/ml. Cyclin mRNA concentrations: 10 and 41 at 2.5 g/ml; 86 and 126 at 3.75 g/ml.
from the use of internal AUGs or from premature termination, interact with immobilized PABP.) We cannot rule out a direct interaction between the various proteins but it is more likely that the added poly(A), which allows multiple molecules of PABP to associate, and the endogenous rabbit reticulocyte PABP, act as bridges for any poly(A)-binding protein, resulting in their association with the GST-PABP variants. In the presence of poly(C), as observed above after RNase treatment, neither the wild type nor the C terminus lacking variant (P10 -370) can bind any of the labeled protein, whereas P237-636 could relatively efficiently bring down the largest of these proteins (1-432), which retains the first 50 amino acids of the C terminus. With further deletions (protein 1-358, which loses the remaining C terminus), this binding is severely impaired (3-fold reduction in binding), although some minor binding can still be seen even with the labeled protein 1-237 (ϳ15% of that observed for protein 1-432). Identical results were obtained with the GST variant P237-542 (data not shown).
Together, these pull-down experiments confirm that the region of the C terminus immediately after the fourth RRM, but excluding the PABC domain, plays a significant role in mediating the interaction between PABP molecules. A role for RRM4 in this self-association is also implied by our findings, because it is required in the GST fusion for maximal interaction (compare P372-636 and P237-542/636; Fig. 5A ) and its removal from the labeled PABP deletion abolishes most of the remaining binding activity to the P237-636 variant in the presence of poly(C) (Fig. 5C) . Alternatively, the residual activity observed between P237-636 and the labeled protein 1-237 may indicate minor binding to the other RRMs, even in the absence of RRM4. This latter observation is consistent with the overall sequence similarity between RRMs 2, 3, and 4 of ϳ45-50% in human PABP, with RRM1 being more divergent. In summary, gel-shift assays and pull-down experiments indicate that RRM4 and the part of the C terminus, up to but not including PABC, mediates PABP self-association. This interaction is dramatically enhanced in the presence of poly(A); in the absence of poly(A), only truncated versions of PABP, lacking RRM1/2, retain the ability to bind other PABP molecules.
Tethered PABP C Terminus Enhances Translation Repression by MS2 of mRNA Containing MS2 Binding Sites in Their 5Ј-UTR-To investigate the role of the C terminus in enhancing translation repression by PABP in vivo, we undertook a tethered strategy whereby MS2 binding sites were inserted in the 5Ј-UTR of CAT reporter genes and, in a second plasmid, the MS2 protein was fused to either the PABP C terminus (amino acids 372-636) or its fourth RRM plus the proximal part of the C terminus (amino acids 237-542 missing the PABC domain), or used alone (Fig. 6A) . The MS2 protein is known to repress translation/expression of reporter genes containing MS2 binding sites in their 5Ј-UTR, as long as it is placed within the first 40 or so nucleotides after the cap. It is not very efficient at preventing translation if the distance between the cap and the MS2 binding site is increased further (43, 47) . Fig. 6 (B and C) 
FIG. 4. Cooperative binding to poly(A) by PABP does not require the PABC domain.
A, A-rich tract from the 5Ј-UTR of the human PABP mRNA used as probe in the assays. B, band-shifts, performed by incubating the 32 P-labeled A-rich probe with increasing concentrations of the PABP proteins P10 -636, P10 -584, P10 -542, and P10 -370 and analysis on a 4% nondenaturing polyacrylamide gel. Protein concentrations used were 0, 0.38, 1.5, 6, and 24 g/ml. The arrows indicate the different protein-RNA complexes. C, translation repression assay with the P10 -542 variant. The 10-, 41-, 86-, and 126-nt distance cyclin mRNAs (Fig. 1C) , as well as the control ⌬(1-263) PABP mRNA, were translated as described in Fig. 3 in the presence of increasing concentrations of P10 -542 (0, 7.5, and 30 g/ml). D, results from C were quantitated and plotted as a function of the recombinant protein concentration.
describes the scheme of the CAT reporters and the MS2 fusion proteins. Two different CAT constructs were made with the high affinity MS2 binding site MSC placed at 15 and 91 nucleotides from the transcription start site, MSC-15 and MSC-91 respectively, and a third construct contained the low affinity MS2 binding site MSA placed at the 15-nucleotide distance, MSA-15 (47) .
Plasmids encoding the reporter genes and the protein fusions were co-transfected in 293 cells along with a third plasmid encoding ␤-galactosidase to serve as transfection control. After 30 -35 h of transfection, the cells were harvested and assayed for CAT and ␤-galactosidase activities. To compensate for variations in transfection efficiency, the ratios between the CAT and ␤-galactosidase activities were determined and for each set of transfections, this ratio was compared with a control transfection where no MS2 expression plasmid was included (Ctrl). In some experiments, RNA was extracted as well and used for Northern blots to confirm approximately equal expression and stability of the different CAT and MS2 genes (Fig. 7D) . First, the cells were transfected with the MSC-15 CAT reporter plasmid along with increasing concentrations of the plasmids expressing the different MS2 fusion proteins (Fig. 7A) . All three proteins led to a dose-dependent decrease in CAT activity, with a maximum reduction of ϳ40%. A minor enhancement of repression was observed by the fusion proteins containing the PABP C terminus. In cells transfected with the reporters containing the mutated MS2 binding site (MSA-15), no reduction in CAT activity was observed for MS2 on its own and less than 20% reduction for the MS2-PABP C terminus fusions, showing that expression of the MS2 fusions is not causing a general nonspecific inhibition of CAT expression (Fig. 7B) . We then analyzed the effect of the fusion proteins on the reporter CAT mRNA bearing a cap-distal MS2 binding site (MSC-91, Fig.  7C ). Although less than 10% reduction of CAT activity was observed even with the highest dose of the MS2 plasmid tested, both fusions containing the PABP fragments were still capable of efficiently (ϳ40% reduction) repressing CAT expression. These effects were largely at the level of translation, as we did not observe corresponding changes in RNA levels (Fig. 7D) . The tethered strategy has also been used by us to specifically investigate reduction in CAT mRNA abundance as well as translation in 293 cells mediated by PABP binding to its 5Ј-UTR (48) . Full-length PABP fused to MS2, like the MS2/C terminus fusions described above, despite reducing the expression of the CAT construct MSC-91, does not affect the reporter mRNA levels.
Initially the transfection results were quite surprising, as we previously showed that the GST-PABP C terminus (P372-636) seemed to have only a limited ability for PABP-PABP binding in the absence of poly(A) (Fig. 5A) . Although we expected the intracellular system to be comparable to a poly(A)-rich envi-
FIG. 5. Delineation of the region required for the interaction between GST-PABP variants and 35 S-labeled PABP.
A, GST-PABP fusion proteins were immobilized on glutathione-Sepharose beads in the presence of BSA and incubated with 35 S-labeled wild type PABP and cyclin A translated in the rabbit reticulocyte lysate. The proteins bound to the beads were eluted in SDS sample buffer and analyzed in SDSpolyacrylamide gels by Coomassie Blue staining and autoradiography. The dots indicate the position of the full-length, undegraded, GST-PABP proteins. The assay was performed in the presence of 5 g/ml poly(A) or after treatment of the reticulocyte lysate with RNase V 1 to eliminate any residual RNA. The lane marked Beads represents the sample where no protein was added to the beads. B, GST-PABP variants were tested for their ability to bind poly(A) in band-shift assays, carried out as described in Fig. 4A but using a 32 P-labeled 63-A RNA probe and 5% nondenaturing polyacrylamide gels. As positive controls, PABP variants P10 -636 and P10 -370 were also included. C, 35 S-labeled PABP deletions were obtained by linearizing PABP cDNA with various restriction enzymes (HindIII for 1-237, MscI for 1-358, and Tth111I for 1-432; the numbers indicate the amino acids remaining in the labeled proteins) followed by transcription with T7 RNA polymerase and translation in the rabbit reticulocyte lysate. The translation reaction was then treated with micrococcal nuclease and incubated with E. coli rRNA and poly(C) or poly(A) (both at 20 g/ml) prior to incubation with the GST-PABP variants indicated. In A and C, the lane marked Retic indicates an equivalent amount of the translation products used in the assay. ronment, we examined whether the N-terminal MS2 portion stabilized the fusion protein (MS2-PABP-(372-636)) and enhanced its ability to bind full-length PABP. Therefore, we took advantage of the fact that the MS2 half of the protein has an N-terminal His tag and tested whether MS2-PABP-(372-636) immobilized on Ni-NTA beads interacts with 35 S-labeled PABP. As shown in Fig. 7E , this protein does indeed bind full-length PABP, even in the absence of poly(A). Control assays were also performed using as the labeled protein a human eIF4G variant (41) , which lacks the motif required for binding PABP while retaining those required to bind eIF4A (16) . No interaction between MS2-PABP-(372-636) and labeled eIF4G is observed (Fig. 7E) . In contrast, recombinant His-tagged human eIF4A can only recover traces of the labeled PABP, while binding very efficiently to labeled eIF4G. These experiments then confirmed that the C terminus on its own, or at least when positioned after an adequate fusion protein, mediates PABP/ PABP interaction and can enhance the limited activity of the RNA-binding protein MS2 in blocking the translation of mRNAs by the small ribosomal subunit at cap-distal positions.
DISCUSSION
The results presented in this report contribute in multiple aspects to the study of the poly(A)-binding protein, with implications both in PABP function/synthesis as well as control of mRNA translation in general. By examining the requirements for PABP to act as a translational repressor, we confirm that PABP can be effective in preventing translation by binding A-tracts at locations both proximal and distal to the cap. In the latter case, PABP very likely blocks the scanning of the 40 S ribosomal subunit along the mRNA, as has been recently shown (38) . However, the ability to bind poly(A) is not sufficient for efficient translational repression at distal sequences, because removal of the PABP C terminus somewhat reduces its ability to inhibit translation (Figs. 3 and 4) . A second significant contribution from this work is the identification, within the PABP C terminus, of the region required for PABP/PABP interaction and cooperative binding to poly(A) (Figs. 4, 5 , and 7). Major implications from this observation will be discussed below.
Translation of PABP mRNA is controlled by at least two independent mechanisms: autoregulation mediated by the PABP protein (25) (26) (27) , and coupling to the cellular growth stage mediated by the polypyrimidine stretch in its 5Ј end (23) . In this study, by using cyclin reporter mRNAs with the A-tracts in their 5Ј-UTR, we were able to concentrate on one aspect of PABP mRNA translation, avoiding the influence of other sequences present in PABP mRNA, which may affect its translation or stability (28) . The A-rich sequence required for PABP mRNA translation repression differs from other sequences that have a similar function such as the IRE, in that it does not easily assume a secondary or tertiary structure, which may prevent ribosomes from scanning along the mRNA. The A-rich sequence also does not need to be positioned proximally to the cap structure (this work and Ref. 38) . We reasoned that specific properties of PABP might be required for it to be an effective repressor and decided to use this activity as a tool to study the contribution of individual domains within PABP to its function. Full-length PABP represses the translation of cyclin mRNAs bearing A-tracts in their 5Ј-UTR, whether the A-tracts are proximal or distal to the cap, although with somewhat higher efficiency in the former case. On the other hand, repression by PABP variants lacking the C terminus is much more sensitive to the distance of the A-tract from the cap (Fig. 3) . Thus, the C-terminal region of the PABP, although not interfering with binding to poly(A), is involved in the repression mechanism. Its role may be to increase the size of the complex bound to the RNA, not only by recruiting other PABP molecules but perhaps also by allowing the association of other proteins to create a multiprotein complex that blocks ribosomal scanning. Previous reports also hint at the contribution of the C terminus to PABP function. In Xenopus oocytes, a minimal PABP consisting of RRMs 1 and 2 did not seem to be able to bind efficiently to mRNAs or prevent their deadenylation when overexpressed in oocytes, in contrast to wild type PABP (49) . In a HeLa-derived cell line, a similar PABP variant (as well as one containing the four RRMs but no C terminus) was still able to bind efficiently 1 and 2) . As a control, His-tagged human eIF4A was immobilized on Ni-NTA beads and incubated with 35 S-labeled PABP or eIF4G (lanes 3 and  4) . Ctrl, control. to poly(A) and shuttle to the cellular nucleus although its export back to the cytoplasm was impaired (22) .
The C-terminal region of PABP was previously reported to be involved in mediating protein/protein interactions, and more specifically PABP multimerization in the presence of poly(A) (12) . The recent description of the PABC domain very much filled a gap in the knowledge about PABP function by mapping the motif involved in interactions with eRF3, PAIP1 and PAIP2 (19, 50, 51) . Our results build upon these discoveries by confirming the participation of the C terminus in PABP/PABP interaction, while ruling out any participation of the PABC domain, and suggest a significant additional contribution of the fourth RRM. These results may relate to those obtained in yeast, where neither the first two RRMs nor the last 50 amino acids, which includes most of the PABC domain, are involved in mRNA stabilization by PABP (21) . The fourth RRM is one of the least characterized of the PABP RRMs. An analysis of sequence conservation of RRMs from PABPs of distantly related organisms shows that RRM 4 is as conserved as RRM 2, which is known to be involved in such important functions as specific poly(A) binding and interaction with eIF4G. In contrast, RRM 3 is much less conserved. RRM 4 has been ascribed roles in cellular viability and in translation (see Introduction), but no interacting factors have yet been identified. Although its involvement in the protein/protein interactions necessary for PABP multimerization may in part explain its conservation (this work), it is also possible that it interacts with still unknown protein or RNA factors (18) .
The region of the C terminus bordered by RRM 4 and the PABC domain first came to notice when PABP sequences from yeast and human were compared, because of its high content of the amino acids proline and glutamine (52) (53) (54) (Fig. 8) . Strikingly, in human PABP, roughly 1 in every 5 or 6 amino acids in this region is proline and 1 in every 3 is either glutamine, asparagine, or arginine, and there are no negatively charged amino acids in the entire 150-amino acid region. Alignments of the C terminus plus the fourth RRMs from PABPs of distantly related organisms shows no consistent sequence homology within this "linker" region, although the bias for the amino acids proline, glutamine, and, to a lesser extent, asparagine and arginine is maintained, as is the lack of acidic residues (Fig. 8) .
Until now, the strongest evidence pointing to the proline glutamine-rich linker region being involved in protein-protein interaction arose from a study of yeast PABP (Pab1p). Pbp1p (for Pab1p-binding protein) was obtained in a screen for factors that interact with the PABP C terminus. The specific interaction between Pab1p and Pbp1p does not require the last 24 amino acids of the PABP C terminus, which includes part of PABC (55) . A likely candidate for mediating the Pab1p/Pbp1p interaction is a segment within the Pab1p linker region (italicized in Fig. 8) found to be partially homologous to two segments in the Pbp1p C terminus. Pab1p mutations that prevent the interaction map within this segment, which was proposed to be involved in homomultimerization (for both Pab1p/Pab1p or Pbp1p/Pbp1p multimers) or heteromultimerization (for Pab1p/Pbp1p multimers). Interestingly, removal of the RRMs from Pab1p actually enhances its binding to Pbp1p (55) . This observation is reminiscent of the PABP pull-down assays described here, where removal of RRMs 1-3 appears to relieve an inhibitory constraint that prevents PABP/PABP interaction in the absence of poly(A). Evidence from various sources indicates that PABP activity can be regulated by different means. An example of such modulation has been observed in mammals, where binding of human eRF3 to PABP abolishes its ability to multimerize when binding to poly(A) (56) . Phosphorylation of plant PABP has also been shown to play a role in regulating its binding to poly(A), because only the modified form binds poly(A) cooperatively (57) . Theoretically, phosphorylation of the proline linker region could reduce its net positive charge and enhance PABP-PABP interaction. Recently, human PABP was identified as a substrate of the coactivator-associated arginine methyltransferase or CARM1 (58) . Modification of target proteins by arginine methyltransferases has been shown to interfere with proteinprotein interactions, and, in one example, the arginine residues flank proline-rich motifs (59) . Intriguingly, the region in PABP methylated by CARM1 has been mapped to the amino acids 384 -478 (58), within the linker region that we show to be involved in PABP-PABP interaction (see Fig. 8 ). However, because the recombinant protein binds cooperatively to poly(A), at least for human PABP, neither methylation nor phosphorylation is probably required for the PABP-PABP interaction. Nevertheless in vivo, these modifications might play an important role in regulating poly(A)-binding and PABP-PABP interactions. Further work is still needed to elucidate these possibilities and to define precisely how the multiple PABP domains interact.
